Back to Top Skip to main content Skip to sub-navigation

Brief Report: Refractive Surgery Trends at Tri-Service Refractive Surgery Centers and the Impact of the COVID-19 Pandemic, Fiscal Years 2000–2020

Image of Cadet Saverio Macrina, U.S. Military Academy West Point, receives corneal cross-linking procedure at Fort Belvoir Community Hospital, Va., Nov. 21, 2016. (DoD photo by Reese Brown). Cadet Saverio Macrina, U.S. Military Academy West Point, receives corneal cross-linking procedure at Fort Belvoir Community Hospital, Va., Nov. 21, 2016. (DOD photo by Reese Brown)

Recommended Content:

Medical Surveillance Monthly Report

Background

Since the official introduction of laser refractive surgery into clinical practice throughout the Military Health System (MHS) in fiscal year 2000, these techniques have been heavily implemented in the tri-service community to better equip and improve the readiness of the U.S. military force. Military studies of refractive surgery date back to 1993, but prior to full military utilization of laser refractive surgery, spectacles or contact lenses were the mainstay to correct refractive error among military personnel.1,2 Studies on the prevalence of refractive error, including myopia, hyperopia, and astigmatism, have shown that these conditions are quite common among active component service members.3,4 Reversing such error through refractive surgery has been documented to improve military readiness, operational capability, and the quality of life of U.S. service members.5

There are 26 Department of Defense (DOD) Warfighter Refractive Surgery Centers that offer a combination of vision-correcting procedures such as photorefractive keratectomy (PRK), laser assisted in situ keratomileusis (LASIK), laser epithelial keratomileusis (LASEK), small incision lenticule extraction (SMILE), implantable collamer lens (ICL), and refractive lens exchange (RLE).6–8 The capability to readily perform surgery with laser technology using the latest refractive surgery platforms highlights the importance of optimized vision to the DOD.

The COVID-19 pandemic introduced numerous obstacles which contributed to the reduction in the number of procedures performed. These obstacles included the closure of surgical centers and lack of temporary duty travel (TDY) patients. The pandemic also resulted in a shift to pre-operative testing for COVID-19 and virtual pre-operative briefings which could potentially result in delayed or cancelled refractive surgeries.

The objective of this report was to describe trends in total numbers of refractive surgeries over the last 21 fiscal years and to demonstrate how the early COVID-19 pandemic affected military refractive surgery trends.

Methods

Data on all refractive surgery cases performed at 26 DOD Warfighter Refractive Surgery Centers were compiled by the U.S. Navy refractive surgery program manager and presented at the 2021 virtual Military Refractive Surgery Safety and Standards Symposium annual meeting.6–8 These data are summarized in this report.

The surveillance period was from 1 October 1999 through 30 September 2020 (fiscal years 2000–2020). The surveillance population included active duty service members (active component and activated Reserve/Guard members) who met eligibility criteria for refractive eye surgery. Criteria for qualifying for refractive surgery may have differed among the services, but in general, service members had to have had at least 18 months left in their service commitments, a commander's authorization letter, and no adverse personnel actions. In addition, 3 Air Force locations performed refractive surgery on a small number of non-service member beneficiaries of the Military Health System as part of a research protocol (accounting for <0.03% of Air Force refractive surgical cases for fiscal year 2020).

Results

For fiscal years 2000–2020, a total of 746,950 refractive surgeries were reported from the 26 Warfighter Tri-Service Refractive Surgery Centers. The number of surgeries performed each fiscal year ranged from a low of 4,381 refractive surgeries in 2000 to a peak of 50,690 surgeries in 2005 (Figure 1) with an average of 35,569 surgeries per year. In fiscal year 2020, 20,270 refractive surgeries were performed which represents a 38.6% decrease from the number of cases performed in 2019 (n=33,039).

During the surveillance period, there were 363,058 surgeries performed at Army refractive centers, 216,568 at Navy refractive centers, and 167,324 at Air Force refractive centers. The number of surgeries for all services declined from fiscal year 2019 to fiscal year 2020 (Army, 39.8% decrease; Navy, 34.6% decrease; Air Force, 41.0% decrease) (Figure 1).

In 2020, the types of refractive surgery approximately consisted of 65.1% PRK (n=13,201), 27.6% LASIK/LASEK (n=5,585), 4.5% SMILE (n=920), 2.7% ICL (n=540), and 0.1% RLE (n=24) (Figure 2). The percentage distributions of type of refractive surgery were similar among all the services in 2020.

Editorial Comment

This report describes trends in the numbers of refractive surgeries performed during the 21 year surveillance period, including the COVID-19 pandemic. Since fiscal year 2000, the tri-service ophthalmology community conducted 746,950 vision corrective surgeries at 26 DOD Warfighter Refractive Surgery Centers. The large number of refractive cases reported and the amount of refractive surgery centers present in the DOD speaks to the valued importance of optimal vision in U.S. military members. In addition to the warfighter's improvement in quality of life, vision corrective surgeries are used frequently in the U.S. military due to the need and for improved preparedness and performance in operational tasks.3–5 An Air Force study from 2020 reported the prevalence of myopia in 767 Air Force Basic Military Trainees. Among the trainees, 45% were found to have myopia classified as greater than -0.5 D, and 2% of trainees were found to have high myopia classified as greater than -6.0 D.In 2019, Reynolds et al. reported that 51.1% of ocular care for service members during fiscal year 2018 was dedicated to refractive error-related disorders.9 A study published in 2017 demonstrated the excellent and comparable vision outcomes of Wave-Front Guided and Wave-Front Optimized PRK on military members in regard to marksmanship, visual performance, threshold target identification, and contrast sensitivity.10 These studies shed light on the importance of refractive surgery offered by the DOD.

When analyzing the effect of the COVID-19 pandemic, a decrease in the number of refractive surgery cases performed in the tri-service community was reported. Specifically, the total number of surgeries during fiscal year 2020 was comparable to the number of surgeries in fiscal year 2002, shortly after the procedures were first introduced. The pronounced decrease in the number of surgeries performed was undoubtedly due to factors related to the SARS-CoV-2 pandemic: shutdown of DOD Warfighter Refractive Surgery Centers, unavailability of TDY patients, pre-operative SARS-CoV-2 testing, difficulty with pre-operative virtual briefings, availability of N-95 masks, properly scheduling post-operative follow-up, and limitations on family members helping with patients after surgery. The reduced number of procedures observed in fiscal year 2020 is consistent with many published reports of reduced health care utilization during the COVID-19 pandemic.11 One such report demonstrated initial reduced demand for refractive surgery which subsequently rebounded in 2021.12

In fiscal year 2020, the majority of cases were PRK followed by LASIK/LASEK and SMILE, respectively. A trend toward PRK surgery in the military has been prevalent for years; however, there has been a shift towards LASIK especially among Navy surgery centers.13,14 Various reasons exist for the preference of PRK, which include surgeon's comfort with performing PRK over LASIK, previous military policies that prohibited LASIK for special forces, and the risk of traumatic corneal flap lifting following LASIK that cannot be attended to in an environment that is not readily equipped with an ophthalmologist (e.g., deployment, training, austere environments).15 With the introduction of SMILE in 2016 after the U.S. Food and Drug Administration approval, it has been increasingly implemented in the DOD.16 SMILE has shown promise with comparable, if not better, visual outcomes than PRK and more predictable outcomes and similar corneal biomechanical stability when compared to LASIK.17,18 The emergence of new refractive surgery techniques will continue to provide opportunity for advancement in military refractive surgery.

Limitations of this study include potential bias in data retrieval and documentation. Data were individually reported from each center and were not verified with medical coding. Additionally, refractive surgeries performed outside of Warfighter Refractive Surgery Centers were not captured in this analysis.

In summary, this report demonstrates the trend in refractive surgeries at the DOD Refractive Surgery Centers and reveals the decrease in refractive surgeries during the COVID-19 pandemic. Because of the instrumental role refractive surgery plays in gaining a strategic advantage for the U.S. military warfighter, surgical procedures still continued during this period and will most likely increase to pre-pandemic numbers as the COVID-related restrictions are lifted or conditions to handle COVID-related spread are improved. Future implications from the lessons learned during the COVID-19 pandemic will provide a framework on how to troubleshoot barriers to performing refractive surgery in the future.

Author affiliations: United States Air Force, Medical College of Georgia at Augusta University (2d Lt Brandon Sellers, BS); United States Air Force, Air Force Refractive Surgery Consultant, Joint Base Elmendorf-Richardson, Anchorage, AK (Lt Col J. Richard Townley, MD); United States Navy, Prior Navy Refractive Surgery Program Manager, Camp Lejeune, Jacksonville, NC (CAPT Corby Ropp, DO); United States Army, Army Refractive Surgery Program Manager, Defense Health Agency Refractive Surgery Board Chair, Brooke Army Medical Center, Ft. Sam Houston, TX (LTC Gary Legault, MD). Dr. Corby Ropp died during the creation of this manuscript but was instrumental in compiling the data.

Disclaimer: The contents, views, or opin­ions expressed in this publication are those of the author(s) and do not necessarily reflect the official policy or position of the Defense Health Agency, Department of Defense, or the U.S. Government.

References

1. Lattimore MR, Jr., Schrimsher RH. Refractive error distribution and incidence among U.S. Army aviators. Mil Med. 1993;158(8):553–556.

2. Hammond MD, Madigan WP, Jr., Bower KS. Refractive surgery in the United States Army, 2000-2003. Ophthalmology. 2005;112(2):184–190.

3. Reynolds ME, Taubman SB, Stahlman S. Incidence and prevalence of selected refractive errors, active component, U.S. Armed Forces, 2001-2018. MSMR. 2019;26(9):26–30.

4. Reed DS, Ferris LM, Santamaria J, et al. Prevalence of myopia in newly enlisted airmen at Joint Base San Antonio. Clin Ophthalmol. 2020;14:133–137.

5. Sia RK, Ryan DS, Rivers BA, et al. Vision-related quality of life and perception of military readiness and capabilities following refractive surgery among active duty U.S. Military service members. J Refract Surg. 2018;34(9):597–603.

6. Legault, GL. Army refractive surgery update. Military Refractive Surgery Safety and Standards Symposium, virtual. 1 January 2021.

7. Townley, JR. Air Force refractive surgery update. Military Refractive Surgery Safety and Standards Symposium, virtual. 1 January 2021.

8. Ropp, C. Navy refractive surgery update. Military Refractive Surgery Safety and Standards Symposium, virtual. 1 January 2021.

9. Reynolds ME, Williams VF, Taubman SB, Stahlman S. Absolute and relative morbidity burdens attributable to ocular and vision-related conditions, active component, U.S. Armed Forces, 2018. MSMR. 2019;26(9):4–11.

10. Ryan DS, Sia RK, Stutzman RD, et al. Wavefront-guided versus wavefront-optimized photorefractive keratectomy: Visual and military task performance. Mil Med. 2017;182(1):e1636–e1644.

11. Moynihan R, Sanders S, Michaleff ZA, et al. Impact of COVID-19 pandemic on utilisation of healthcare services: a systematic review. BMJ Open. 2021;11(3):e045343. 

12. Bickford M, Rocha K. Impact of the COVID-19 pandemic on refractive surgery. Curr Ophthalmol Rep. 2021:1–6.

13. Stanley PF, Tanzer DJ, Schallhorn SC. Laser refractive surgery in the United States Navy. Curr Opin Ophthalmol. 2008 Jul;19(4)321–324.

14. Gao H, Miles TP, Troche R, et al. Quality of vision following LASIK and PRK-MMC for treatment of myopia. Mil Med. 2021;usab071. 

15. Shih LY, Peng KL, Chen JL. Traumatic displacement of laser in situ keratomileusis flaps: an integrated clinical case presentation. BMC Ophthalmol. 2021;21(1):177.

16. Dishler JG, Slade S, Seifert S, Schallhorn SC. Small-incision lenticule extraction (SMILE) for the correction of myopia with astigmatism: Outcomes of the United States Food and Drug Administration Premarket Approval Clinical Trial. Ophthalmology. 2020;127(8):1020–1034.

17. Sia RK, Ryan DS, Beydoun H, et al. Visual outcomes after SMILE from the first-year experience at a U.S. military refractive surgery center and comparison with PRK and LASIK outcomes. J Cataract Refract Surg. 2020;46(7):995–1002.

18. Cao K, Liu L, Yu T, Chen F, Bai J, Liu T. Changes in corneal biomechanics during small-incision lenticule extraction (SMILE) and femtosecond-assisted laser in situ keratomileusis (FS-LASIK). Lasers Med Sci. 2020;35(3):599–609.

FIGURE 1. Number of refractive surgery cases, by service from a Tri-Service Refractive Surgery Center, fiscal years 2000–2020

FIGURE 2. Refractive surgery cases, by service and type of procedure performed at a Tri- Service Refraction Surgery Center, fiscal year 2020

You also may be interested in...

Testosterone Replacement Therapy Use Among Active Component Service Men, 2017

Article
3/1/2019
Image of Marines carrying a wooden log for physical fitness. Click to open a larger version of the image.

This analysis summarizes the prevalence of testosterone replacement therapy (TRT) during 2017 among active component service men by demographic and military characteristics. This analysis also determines the percentage of those receiving TRT in 2017 who had an indication for receiving TRT using the 2018 American Urological Association (AUA) clinical practice guidelines. In 2017, 5,093 of 1,076,633 active component service men filled a prescription for TRT, for a period prevalence of 4.7 per 1,000 male service members. After adjustment for covariates, the prevalence of TRT use remained highest among Army members, senior enlisted members, warrant officers, non-Hispanic whites, American Indians/Alaska Natives, those in combat arms occupations, healthcare workers, those who were married, and those with other/unknown marital status. Among active component male service members who received TRT in 2017, only 44.5% met the 2018 AUA clinical practice guidelines for receiving TRT.

Recommended Content:

Medical Surveillance Monthly Report

Update: Malaria, U.S. Armed Forces, 2018

Article
2/1/2019
Anopheles merus

Malaria infection remains an important health threat to U.S. service mem­bers who are located in endemic areas because of long-term duty assign­ments, participation in shorter-term contingency operations, or personal travel. In 2018, a total of 58 service members were diagnosed with or reported to have malaria. This represents a 65.7% increase from the 35 cases identi­fied in 2017. The relatively low numbers of cases during 2012–2018 mainly reflect decreases in cases acquired in Afghanistan, a reduction due largely to the progressive withdrawal of U.S. forces from that country. The percentage of cases of malaria caused by unspecified agents (63.8%; n=37) in 2018 was the highest during any given year of the surveillance period. The percent­age of cases identified as having been caused by Plasmodium vivax (10.3%; n=6) in 2018 was the lowest observed during the 10-year surveillance period. The percentage of malaria cases attributed to P. falciparum (25.9 %) in 2018 was similar to that observed in 2017 (25.7%), although the number of cases increased. Malaria was diagnosed at or reported from 31 different medical facilities in the U.S., Afghanistan, Italy, Germany, Djibouti, and Korea. Pro­viders of medical care to military members should be knowledgeable of and vigilant for clinical manifestations of malaria outside of endemic areas.

Recommended Content:

Medical Surveillance Monthly Report

Update: Incidence of Glaucoma Diagnoses, Active Component, U.S. Armed Forces, 2013–2017

Article
2/1/2019
Glaucoma

Glaucoma is an eye disease that involves progressive optic nerve damage and vision loss, leading to blindness if undetected or untreated. This report describes an analysis using the Defense Medical Surveillance System to identify all active component service members with an incident diagnosis of glaucoma during the period between 2013 and 2017. The analysis identified 37,718 incident cases of glaucoma and an overall incidence rate of 5.9 cases per 1,000 person-years (p-yrs). The majority of cases (97.6%) were diagnosed at an early stage as borderline glaucoma; of these borderline cases, 2.2% progressed to open-angle glaucoma during the study period. No incident cases of absolute glaucoma, or total blindness, were identified. Rates of glaucoma were higher among non-Hispanic black (11.0 per 1,000 p-yrs), Asian/Pacific Islander (9.5), and Hispanic (6.9) service members, compared with non-Hispanic white (4.0) service members. Rates among female service members (6.6 per 1,000 p-yrs) were higher than those among male service members (5.8). Between 2013 and 2017, incidence rates of glaucoma diagnoses increased by 75.4% among all service members.

Recommended Content:

Medical Surveillance Monthly Report

Re-evaluation of the MSMR Case Definition for Incident Cases of Malaria

Article
2/1/2019
Anopheles merus

The MSMR has been publishing the results of surveillance studies of malaria since 1995. The standard MSMR case definition uses Medical Event Reports and records of hospitalizations in counting cases of malaria. This report summarizes the performance of the standard MSMR case definition in estimating incident cases of malaria from 2015 through 2017. Also explored was the potential surveillance value of including outpatient encounters with diagnoses of malaria or positive laboratory tests for malaria in the case definition. The study corroborated the relative accuracy of the MSMR case definition in estimating malaria incidence and provided the basis for updating the case definition in 2019 to include positive laboratory tests for malaria antigen within 30 days of an outpatient diagnosis.

Recommended Content:

Medical Surveillance Monthly Report

Outbreak of Acute Respiratory Illness Associated with Adenovirus Type 4 at the U.S. Naval Academy, 2016

Article
2/1/2019
Malaria case definition

Human adenoviruses (HAdVs) are known to cause respiratory illness outbreaks at basic military training (BMT) sites. HAdV type-4 and -7 vaccines are routinely administered at enlisted BMT sites, but not at military academies. During August–September 2016, U.S. Naval Academy clinical staff noted an increase in students presenting with acute respiratory illness (ARI). An investigation was conducted to determine the extent and cause of the outbreak. During 22 August–11 September 2016, 652 clinic visits for ARI were identified using electronic health records. HAdV-4 was confirmed by real-time polymerase chain reaction assay in 18 out of 33 patient specimens collected and 1 additional HAdV case was detected from hospital records. Two HAdV-4 positive patients were treated for pneumonia including 1 hospitalized patient. Molecular analysis of 4 HAdV-4 isolates identified genome type 4a1, which is considered vaccine-preventable. Understanding the impact of HAdV in congregate settings other than enlisted BMT sites is necessary to inform discussions regarding future HAdV vaccine strategy.

Recommended Content:

Medical Surveillance Monthly Report

Thyroid Disorders, Active Component, U.S. Armed Forces, 2008–2017

Article
12/1/2018

This analysis describes the incidence and prevalence of five thyroid disorders (goiter, thyrotoxicosis, primary/not otherwise specified [NOS] hypothyroidism, thyroiditis, and other disorders of the thyroid) among active component service members between 2008 and 2017. During the 10-year surveillance period, the most common incident thyroid disorder among male and female service members was primary/NOS hypothyroidism and the least common were thyroiditis and other disorders of thyroid. Primary/NOS hypothyroidism was diagnosed among 8,641 females (incidence rate: 43.7 per 10,000 person-years [p-yrs]) and 11,656 males (incidence rate: 10.2 per 10,000 p-yrs). Overall incidence rates of all thyroid disorders were 3 to 5 times higher among females compared to males. Among both males and females, incidence of primary/NOS hypothyroidism was higher among non-Hispanic white service members compared with service members in other race/ethnicity groups. The incidence of most thyroid disorders remained stable or decreased during the surveillance period. Overall, the prevalence of most thyroid disorders increased during the first part of the surveillance period and then either decreased or leveled off.31.6 per 100,000 active component service members in 2017. Validation of ICD-9/ICD-10 diagnostic codes for MetS using the National Cholesterol Education Program Adult Treatment Panel III criteria is needed to establish the level of agreement between the two methods for identifying this condition.

Recommended Content:

Medical Surveillance Monthly Report

Adrenal Gland Disorders, Active Component, U.S. Armed Forces, 2002–2017

Article
12/1/2018

During 2002–2017, the most common incident adrenal gland disorder among male and female service members was adrenal insufficiency and the least common was adrenomedullary hyperfunction. Adrenal insufficiency was diagnosed among 267 females (crude overall incidence rate: 8.2 cases per 100,000 person-years [p-yrs]) and 729 males (3.9 per 100,000 p-yrs). In both sexes, overall rates of other disorders of adrenal gland and Cushing’s syndrome were lower than for adrenal insufficiency but higher than for hyperaldosteronism, adrenogenital disorders, and adrenomedullary hyperfunction. Crude overall rates of adrenal gland disorders among females tended to be higher than those of males, with female:male rate ratios ranging from 2.1 for adrenal insufficiency to 5.5 for androgenital disorders and Cushing’s syndrome. The highest overall rates of adrenal insufficiency for males and females were among non-Hispanic white service members. Among females, rates of Cushing’s syndrome and other disorders of adrenal gland were 31.6 per 100,000 active component service members in 2017. Validation of ICD-9/ICD-10 diagnostic codes for MetS using the National Cholesterol Education Program Adult Treatment Panel III criteria is needed to establish the level of agreement between the two methods for identifying this condition.

Recommended Content:

Medical Surveillance Monthly Report

Incidence and Prevalence of the Metabolic Syndrome Using ICD-9 and ICD-10 Diagnostic Codes, Active Component, U.S. Armed Forces, 2002–2017

Article
12/1/2018

This report uses ICD-9 and ICD-10 codes (277.7 and E88.81, respectively) for the metabolic syndrome (MetS) to summarize trends in the incidence and prevalence of this condition among active component members of the U.S. Armed Forces between 2002 and 2017. During this period, the crude overall incidence rate of MetS was 7.5 cases per 100,000 person-years (p-yrs). Compared to their respective counterparts, overall incidence rates were highest among Asian/Pacific Islanders, Air Force members, and warrant officers and were lowest among those of other/unknown race/ethnicity, Marine Corps members, and junior enlisted personnel and officers. During 2002–2017, the annual incidence rates of MetS peaked in 2009 at 11.6 cases per 100,000 p-yrs and decreased to 5.9 cases per 100,000 p-yrs in 2017. Annual prevalence rates of MetS increased steadily during the first 11 years of the surveillance period reaching a high of 38.9 per 100,000 active component service members in 2012, after which rates declined slightly to 31.6 per 100,000 active component service members in 2017. Validation of ICD-9/ICD-10 diagnostic codes for MetS using the National Cholesterol Education Program Adult Treatment Panel III criteria is needed to establish the level of agreement between the two methods for identifying this condition.

Recommended Content:

Medical Surveillance Monthly Report
<< < ... 11 12 > >> 
Showing results 166 - 173 Page 12 of 12
Refine your search
Last Updated: May 23, 2022

DHA Address: 7700 Arlington Boulevard | Suite 5101 | Falls Church, VA | 22042-5101

Some documents are presented in Portable Document Format (PDF). A PDF reader is required for viewing. Download a PDF Reader or learn more about PDFs.